2025-03-12 12:55:27
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Anuh Pharma Q3FY22 PAT falls QoQ to Rs. 7.44 crores
Posted On : 2022-02-04 18:57:27( TIMEZONE : IST )
ANUH PHARMA LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 132.0029 crores during the period ended December 31, 2021 as compared to Rs. 10.6455 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 7.4480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 8.5974 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 1.49 for the period ended December 31, 2021 as compared to Rs. 1.72 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹132.0029 crs | ₹10.6455 crs |  1,139.99% |
| Net Profit | ₹7.4480 crs | ₹8.5974 crs |  -13.37% |
| EPS | ₹1.49 | ₹1.72 | -13.37% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs.132.0029 crores during the period ended December 31, 2021 as compared to Rs.100.8432 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.7.4480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.4.1801 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.1.49 for the period ended December 31, 2021 as compared to Rs.0.83 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹132.0029 crs | ₹100.8432 crs | 30.90% |
| Net Profit | ₹7.4480 crs | ₹4.1801 crs | 78.18% |
| EPS | ₹1.49 | ₹0.83 | 79.52% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.361.8446 crores during the 9 Months period ended December 31, 2021 as compared to Rs.343.7915 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.21.6357 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.27.5394 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.4.32 for the 9 Months period ended December 31, 2021 as compared to Rs.5.50 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹361.8446 crs | ₹343.7915 crs | 5.25% |
| Net Profit | ₹21.6357 crs | ₹27.5394 crs | -21.44% |
| EPS | ₹4.32 | ₹5.50 | -21.45% |
Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 114.85 as compared to the previous close of Rs. 110.80. The total number of shares traded during the day was 41761 in over 355 trades.
The stock hit an intraday high of Rs. 115.50 and intraday low of 111.35. The net turnover during the day was Rs. 4773991.00.
